Abstract
Purpose
Although lower levels of vitamin D have been related to poor cognitive functioning and dementia in older adults, evidence from longitudinal investigations is inconsistent. The objective of this study was to determine whether 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels are associated with specified measures of cognitive decline in ageing men.
Methods
The European Male Ageing Study (EMAS) followed 3369 men aged 40–79 over 4.4 years. 25(OH)D levels at baseline were measured by radioimmunoassay, and 1,25(OH)2D levels were obtained with liquid chromatography–tandem mass spectrometry. Visuoconstructional abilities, visual memory, and processing speed at baseline and follow-up were assessed using the Rey–Osterrieth Complex Figure Test (ROCF), Camden Topographical Recognition Memory (CTRM), and the Digit Symbol Substitution Test (DSST).
Results
Following attritions, a total of 2430 men with a mean (SD) age of 59.0 (10.6) were included in the analyses. At baseline, the mean 25(OH)D concentration was 64.6 (31.5) nmol/l, and mean 1,25(OH)2D level was 59.6 (16.6) pmol/l. In age-adjusted linear regression models, high 25(OH)D concentrations were associated with a smaller decline in the DSST (β = 0.007, p = 0.020). Men with low 25(OH)D levels (<50 nmol/l) showed a greater decline in the CTRM compared to men with higher (≥75 nmol/l) levels (β = −0.41, p = 0.035). However, these associations disappeared after adjusting for confounders such as depressive symptoms, BMI, and comorbidities. There was no indication of a relationship between 1,25(OH)2D and decline in cognitive subdomains.
Conclusion
We found no evidence for an independent association between 25(OH)D or 1,25(OH)2D levels and visuoconstructional abilities, visual memory, or processing speed over on average 4.4 years in this sample of middle-aged and elderly European men.
Similar content being viewed by others
References
Holick MF (2007) Vitamin D deficiency. New Engl J Med 357:266–281
Cashman KD, Dowling KG, Ŝkrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, Moreno L, Damsgaard CT, Michaelsen KF, Mølgaard C, Jorde R, Grimnes G, Moschonis G, Mavrogianni C, Manios Y, Thamm M, Mensink GBM, Rabenberg M, Busch MA, Cox L, Meadows S, Goldberg G, Prentice A, Dekker JM, Nijpels G, Pilz S, Swart KM, Van Schoor NM, Lips P, Eiriksdottir G, Gudnason V, Cotch MF, Koskinen S, Lamberg-Allardt C, Durazo-Arvizu RA, Sempos CT, Kiely M (2016) Vitamin D deficiency in Europe: pandemic. Am J Clin Nutr. doi:10.3945/ajcn.115.120873
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930
Kesby JP, Eyles DW, Burne TH, McGrath JJ (2011) The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol 347:121–127
Chabas JF, Alluin O, Rao G, Garcia S, Lavaut M, Risso JJ, Legre R, Magalon G, Khrestchatisky M, Marqueste T, Decherchi P, Feron F (2008) Vitamin D2 potentiates axon regeneration. J Neurotraum 25:1247–1256
Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 21:98–108
Marini F, Bartoccini E, Cascianelli G, Voccoli V, Baviglia MG, Magni MV, Garcia-Gil M, Albi E (2010) Effect of 1α,25-dihydroxyvitamin D3 in embryonic hippocampal cells. Hippocampus 20:696–705
Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden E, Rosenthal MJ, Ilka N, Ringman J, Teplow DB (2013) 1α, 25-Dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer’s disease patients. J Alzheimers Dis 34:155–170
Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PHM, Fried L, Kestenbaum BR, Kuller LH, Langa KM, Lopez OL, Kos K, Soni M, Llewellyn DJ (2014) Vitamin D and the risk of dementia and Alzheimer disease. Neurology 83:920–928
Van der Schaft J, Koek HL, Dijkstra E, Verhaar HJJ, Van der Schouw YT, Emmelot-Vonk MH (2013) The association between vitamin D and cognition: a systematic review. Ageing Res Rev 12:1013–1023
Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P (2012) Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 79:1397–1405
Schlögl M, Holick MF (2014) Vitamin D and neurocognitive function. Clin Interv Aging 9:559–568
Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170:1135–1141
Wilson VK, Houston DK, Kilpatrick L, Lovato J, Yaffe K, Cauley JA, Harris TB, Simonsick EM, Ayonayon HN, Kritchevsky SB, Sink KM (2014) Relationship between 25-hydroxyvitamin D and cognitive function in older adults. J Am Geriatr Soc 62:636–641
Slinin Y, Paudel M, Taylor BC, Ishani A, Rossom R, Yaffe K, Blackwell T, Lui L, Hochberg M, Ensrud KE (2012) Association between serum 25 (OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci 67:1092–1098
Granic A, Hill TR, Kirkwood TBL, Davies K, Collerton J, Martin-Ruiz C, Von Zglinicki T, Saxby BK, Wesnes KA, Collerton D, Mathers JC, Jagger C (2015) Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study. Eur J Neurol 22:106–e107
Bartali B, Devore E, Grodstein F, Kang JH (2014) Plasma vitamin D levels and cognitive function in aging women: the Nurses’ Health Study. J Nutr Health Aging 18:400–406
Schneider ALC, Lutsey PL, Alonso A, Gottesman RF, Sharrett AR, Carson KA, Gross M, Post WS, Knopman DS, Mosley TH, Michos ED (2014) Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study. Eur J Neurol 21:1211–1218
Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Canales MT, Yaffe K, Barrett-Connort E, Orwoll ES, Shikany JM, LeBlanc ES, Cauley JA, Ensrud KE (2010) 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 74:33–41
Breitling LP, Perna L, Müller H, Raum E, Kliegel M, Brenner H (2012) Vitamin D and cognitive functioning in the elderly population in Germany. Exp Gerontol 47:122–127
Seamans KM, Hill TR, Scully L, Meunier N, Andrillo-Sanchez M, Polito A, Hininger-Favier I, Ciarapica D, Simpson EEA, Steward-Knox BJ, O’Connor JM, Coudray C, Cashman KD (2010) Vitamin D status and measures of cognitive function in healthy older European adults. Eur J Clin Nutr 64:1172–1178
McGrath J, Scragg R, Chant D, Eyles D, Burne T, Obradovic (2007) No association between serum 25-hydroxyvitamin D3 level and performance on psychometric tests in NHANES III. Neuroepidemiology 29:49–54
Annweiler C, Beauchet O (2014) Vitamin D in older adults: the need to specify standard values with respect to cognition. Front Aging Neurosci 6:72
Lee DM, O’Neill TW, Pye SR, Silman AJ, Finn JD, Pendleton N, Tajar A, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D, Wu FCW (2009) The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 32:11–24
Lee DM, Tajar A, Ulubaev A, Pendleton N, O’Neill TW, O’Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean MEJ, Punab M, Silman AJ, Vanderschueren D, Wu FCW (2009) Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 80:722–729
Prentice A, Goldberg GR, Schoenmakers I (2008) Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 88:500S–506S
Hibler EA, Sardo Molmenti CL, Lance P, Jurutka PW, Jacobs ET (2014) Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma. Cancer Causes Control 25:809–817
Bea JW, Jurutka PW, Hibler EA, Lance P, Martínez ME, Roe DJ, Sardo Molmenti CL, Thompson PA, Jacobs ET (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447–459
Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio
Reuben DB, Siu AL (1990) An objective measure of physical function of elderly outpatients: the Physical Performance Test. J Am Geriatr Soc 38:1105–1112
Osterrieth PA (1944) Le test de copie d’une figure complexe. Arch Psychol 30:206–356
Warrington EK (1996) The Camden memory tests manual, vol 1. Psychology Press, Abingdon
Uiterwijk JM (2001) WAIS-III-NL-V. Swets & Zeitlinger, Lisse
Vanderschueren D, Pye SR, O’Neill TW, Lee DM, Jans I, Billen J, Gielen E, Laurent M, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean MEJ, Pendleton N, Punab M, Wu FCW, Boonen S (2013) Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Ageing Study (EMAS). J Clin Endocrinol Metab 98:995–1005
Cleveland WS (1979) Robust locally weighted fitting and smoothing scatterplots. J Am Stat Assoc 74:829–836
Anglin RES, Samaan Z, Walter SD, McDonald SD (2013) Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry 202:100–107
Lee DM, Tajar A, O’Neill TW, O’Connor DB, Bartfai G, Boonen S, Bouillon R, Casanueva FF, Finn JD, Forti G, Han TS, Huhtaniemi IT, Kula K, Lean MEJ, Punab M, Silman AJ, Vanderschueren D, Wu FCW, Pendleton N (2011) Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol 25:1320–1328
Culpepper L (2015) Impact of untreated major depressive disorder on cognition and daily function. J Clin Psychiatry 76:e901
Jones G (2008) Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88:582S–586S
Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650–657
Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14:1032–1040
Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL (2009) Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 64A:888–895
Menant JC, Close JCT, Delbaere K, Sturnieks DL, Trollor J, Sachdev PS, Brodaty H, Lord SR (2012) Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women. Osteoporos Int 23:981–989
Briones TL, Darwish H (2014) Decrease in age-related tau hyperphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state. Neuroscience 262:143–155
Dean AJ, Bellgrove MA, Hall T, Phan WMJ, Eyles DW, Kvaskoff D, McGrath JJ (2011) Effects of vitamin D supplementation on cognitive and emotional functioning in young adults: a randomised controlled trial. PLoS ONE 6:e25966
Rossom RC, Espeland MA, Manson JE, Dysken MW, Johnson KC, Lane DS, LeBlanc ES, Lederie FA, Masaki KH, Margolis KL (2012) Calcium and vitamin D supplementation and cognitive impairment in the women’s health initiative. J Am Geriatr Soc 60:2197–2205
Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G (2010) Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 13 months in an intervention study. Am J Epidemiol 171:903–908
Bird CM, Papadopoulou K, Ricciardelli P, Rossor MN, Cipolotti L (2004) Monitoring cognitive changes: psychometric properties of six cognitive tests. Br J Clin Psychol 43:197–210
Acknowledgments
The authors wish to thank the participating patients in the eight countries and the following research and nursing staff for their data collection: C Pott, Manchester; E Wouters, Leuven; M Nilsson, Malmö; M del Mar Fernandez, Santiago de Compostela; M Jedrzejowska, Łódź; H-M Tabo, Tary; and A Heredi, Szeged. The authors also wish to thank C Moseley, Manchester, for data entry and project coordination, and E van Herck, Leuven, for performing the 25(OH)D assays. The EMAS Study Group members are based in the following cities: Florence, Italy (Gianni Forti, Luisa Petrone, Giovanni Corona); Leuven, Belgium (Dirk Vanderschueren, Herman Borghs, Leen Antonio); Łódź, Poland (Krzysztof Kula, Jolanta Slowikowska-Hilczer, Renata Walczak-Jedrzejowska); London, UK (Ilpo Huhtaniemi); Malmö, Sweden (Aleksander Giwercman); Manchester, UK (Frederick Wu, Alan Silman, Neil Pendleton, Terence O’Neill, Joseph Finn, Philip Steer, David Lee, Stephen Pye); Santiago de Compostela, Spain (Felipe Casanueva, Ana I Castro); Szeged, Hungary (Gyorgy Bartfai, Imre Földesi, Imre Fejes); and Tartu, Estonia (Margus Punab, Paul Korrovitz).
Funding
The European Male Ageing Study is funded by the Commission of the European Communities Fifth Framework Program “Quality of Life and Management of Living Resources” Grant QLK6-CT-2001-00258. Additional support was provided by the Arthritis Research Campaign (UK).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
Prof. D. Vanderschueren is employed as a senior clinical investigator of the University Hospitals Leuven. The remaining authors have no competing interests to disclose.
Ethical standards
Ethical approval for this study was obtained in agreement with local institutional requirements at each centre. Written informed consent was provided by all the participants prior to their inclusion in the study.
Rights and permissions
About this article
Cite this article
Overman, M.J., Pendleton, N., O’Neill, T.W. et al. Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study. Eur J Nutr 56, 2093–2103 (2017). https://doi.org/10.1007/s00394-016-1247-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-016-1247-4